The assay showed a significant increase in PLSCR4 expression in SCD patients in VOC (0.856 ng/ml) compared to SCD patient in steady-state (0.238 ng/ml) (p = 9.072e−6) (Fig. 4b). This evidence concerns the gene PLSCR4 and Schnyder corneal dystrophy.